SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-22-003398
Filing Date
2022-03-10
Accepted
2022-03-10 16:43:19
Documents
4
Effectiveness Date
2022-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_q3_fy22.htm S-8 160495
2 EX-5.1 kalv-ex5_1.htm EX-5.1 24522
3 EX-23.1 kalv-ex23_1.htm EX-23.1 2798
4 EX-FILING FEES kalv-ex99_f.htm EX-FILING FEES 32723
  Complete submission text file 0000950123-22-003398.txt   221868
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-263431 | Film No.: 22729653
SIC: 2834 Pharmaceutical Preparations